• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
The Analysis Factor

The Analysis Factor

Statistical Consulting, Resources, and Statistics Workshops for Researchers

  • Home
  • Our Programs
    • Membership
    • Online Workshops
    • Free Webinars
    • Consulting Services
  • About
    • Our Team
    • Our Core Values
    • Our Privacy Policy
    • Employment
    • Collaborate with Us
  • Statistical Resources
  • Contact
  • Blog
  • Login

What Is Regression to the Mean?

by Audrey Schnell Leave a Comment

by Audrey Schnell, PhD

Have you ever heard that “2 tall parents will have shorter children”?

This phenomenon, known as regression to the mean, has been used to explain everything from patterns in hereditary stature (as Galton first did in 1886) to why movie sequels or sophomore albums so often flop.

So just what is regression to the mean (RTM)?

RTM is a statistical phenomenon that occurs when unusually large or unusually small measurement values are followed by values that are closer to the population mean. This is due to random measurement error or, put another way, non-systematic fluctuations around the true mean.

The problem is that RTM can make the predictable change in repeated measures look like meaningful change due to a treatment.

RTM is a particular concern in two situations:

  1. Pre-post intervention study designs that target “high risk” groups (e.g., individuals with high blood pressure)
  2. Two-phase sampling designs where a subset of the first sample based on initial value is chosen for further study (e.g., when selecting the highest or lowest risk group for sub-analyses or follow-up).

Luckily, there are corrections you can make at the design phase and/or analysis phase to minimize the risk of RTM.

The best solution, say most authors, is an appropriately designated control group.

A classic example is Reader, et al.’s trial in mild hypertensive patients (1980). Subjects were classified into 3 groups based on their screening values and randomized to treatment or control.

The following two tables show the baseline and follow-up values for the treatment and control groups:

Treatment:

Screening DBP
group (mm Hg)

Mean screening
DBP (mm Hg)

Mean DBP on
treatment (mm Hg)

Mean fall in
DBP (mm Hg)

95-99

96.9

87.2

9.7

100-104

101.9

88.8

13.1

105-109

106.7

90.2

16.5

 

Control/Placebo:

Screening DBP
group (mm Hg)

Mean screening
DBP (mm Hg)

Mean DBP on
placebo (mm Hg)

Mean fall in
DBP (mm Hg)

95-99

97.0

92.1

5.0

100-104

101.9

94.5

7.4

105-109

106.7

97.5

9.2

 

In both groups, as you can see, the more extreme the initial diastolic blood pressure (DBP), the greater the decline. However, the treatment group experiences a much greater improvement.

Without the appropriate control group for comparison, it would be difficult to conclude the decline was not just due to regression to the mean. (It’s important to note, however, that using a control group may not be a complete solution when extreme values are chosen).

In the design phase, another approach to minimizing RTM would be to take 2 sets of baseline measurements at 2 different times — one baseline measurement to select groups, and the other baseline measure as a covariate. (Alternatively, using the mean of several baseline measurements for the pre-value will be closer to the true mean than a single measurement).

Once you get into the analysis phase, graphs are a helpful way of detecting RTM (for example, a scatter plot of post-pre values plotted against baseline). In this phase, some authors suggest using analysis of covariance as the best method rather than difference scores (the post-pre values).

For a sub-group analysis (i.e., subgroup based on extreme values), if the total population mean and the correlation for pre- and post- measurements are known, there are formulas for correcting for RTM. (There are other formulas for correcting for RTM using the within-subject and between-subject variance, but this only applies to normally distributed data.)

The goal of all this, of course, is to become aware of RTM so we know how it can affect results. I focused on health-related data here, but regression to the mean is not limited to biological data – it can occur in any setting. And even when we can detect RTM and understand the theory, seeing how it affects our own research may still be tricky.

References:

Regression to the mean: what it is and how to deal with it. Adrian G Barnett, Jolieke C van der Pols and Annette J Dobson. International Journal of Epidemiology 2005;34:215–220.

The need to control for regression to the mean in social psychology studies. Rongjun Yu and LiChen. Frontiers in Psychology. January 2015 Volume 5 1574.

Correcting for Regression to the Mean in Behavior and Ecology. Colleen Kelly and Trevor D. Price. The American Naturalist.  Vol. 166, no. 6 December 2005.

Regression towards the mean or Why was Terminator III such a disappointment? Martin Bland. Talk first presented to the Commission for Health Improvement. January 2004.

Assessing regression to the mean effects in health care initiatives. Ariel Linden. BMC Medical Research Methodology 2013, 13:119.

Four Critical Steps in Building Linear Regression Models
While you’re worrying about which predictors to enter, you might be missing issues that have a big impact your analysis. This training will help you achieve more accurate results and a less-frustrating model building experience.

Tagged With: pre-post design, regression to the mean, Repeated Measures, two-phase sampling

Related Posts

  • Analyzing Pre-Post Data with Repeated Measures or ANCOVA
  • Why report estimated marginal means?
  • What are Sums of Squares?
  • When Unequal Sample Sizes Are and Are NOT a Problem in ANOVA

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Please note that, due to the large number of comments submitted, any questions on problems related to a personal study/project will not be answered. We suggest joining Statistically Speaking, where you have access to a private forum and more resources 24/7.

Primary Sidebar

This Month’s Statistically Speaking Live Training

  • Member Training: Analyzing Pre-Post Data

Upcoming Free Webinars

Poisson and Negative Binomial Regression Models for Count Data

Upcoming Workshops

  • Analyzing Count Data: Poisson, Negative Binomial, and Other Essential Models (Jul 2022)
  • Introduction to Generalized Linear Mixed Models (Jul 2022)

Copyright © 2008–2022 The Analysis Factor, LLC. All rights reserved.
877-272-8096   Contact Us

The Analysis Factor uses cookies to ensure that we give you the best experience of our website. If you continue we assume that you consent to receive cookies on all websites from The Analysis Factor.
Continue Privacy Policy
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT